(Q36600303)

English

Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator

scientific article published on October 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Ameae M Walker

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1257-1267

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Pituitary production of prolactin and prolactin-suppressing drugs.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Prolactin and prolactin receptors in the lacrimal gland

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Prolactin acts as a potent survival factor for human breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

The cytokine receptor superfamily

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Phosphorylated and nonphosphorylated Prolactin isoforms

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Secretion of specific nonphosphorylated and phosphorylated rat prolactin isoforms at different stages of the estrous cycle.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Thiol regulation of protein, growth hormone, and prolactin release from isolated adenohypophysial secretory granules

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Biosynthesis of the secreted 24 K isoforms of prolactin

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

p21-activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Identification of the major site of rat prolactin phosphorylation as serine 177.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Plasma prolactin and prostate cancer risk: A prospective study

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Prostate development and carcinogenesis in prolactin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Prostate carcinogenesis and inflammation: emerging insights.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Targeting neovascular pericytes in neurofibromatosis type 1.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Tissue inhibitor of metalloproteinases-1 stimulates gene expression in MDA-MB-435 human breast cancer cells by means of its ability to inhibit metalloproteinases

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Two CD95 (APO-1/Fas) signaling pathways

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Bromocriptine treatment of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

The Role of Prolactin in the Prostatic Inflammatory Response to Neonatal Estrogen

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Development of new prolactin analogs acting as pure prolactin receptor antagonists

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Development of pure prolactin receptor antagonists.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Identification and characterization of the prolactin-binding protein in human serum and milk

1 reference

https://api.crossref.org/works/10.1517%2F13543784.15.10.1257

21 January 2018

Identifiers

10.1517/13543784.15.10.1257

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36600303&oldid=1856264187"